Literature DB >> 21677895

A randomized crossover trial of the effect of a novel method of pressure control (SensAwake) in automatic continuous positive airway pressure therapy to treat sleep disordered breathing.

George C Dungan1, Nathaniel S Marshall, Camilla M Hoyos, Brendon J Yee, Ronald R Grunstein.   

Abstract

OBJECTIVES: To study the acute effect of the new SensAwake CPAP modality (reducing pressure on awakenings) on wake after sleep onset (WASO) and other polysomnographic measures in patients with obstructive sleep apnea (OSA). STUDY
DESIGN: Randomized crossover trial comparing an automatic continuous positive airway pressure device (AutoCPAP) with and without SensAwake on sleep architecture. CPAP naive patients received each therapy for a single night in the laboratory with at least 1-week washout. Both patients' and technicians' subjective satisfaction was assessed. Pressure data measured and stored by the AutoCPAP device were also analyzed.
RESULTS: OSA was controlled adequately by both modes (SensAwake ON apnea hypopnea index ± SD, AHI = 5.3 ± 5.6/h vs. SensAwake OFF = 5.4 ± 5.8, p = 0.9) in the 42 patients who completed the protocol. Mean and 90% pressures were significantly lower with SensAwake (mean ON = 6.9 ± 1.9 vs. OFF = 7.7 ± 2.5 cm H(2)O, p < 0.05; 90% pressure ON = 9.6 ± 2.7 vs. OFF = 10.6 ± 2.7 cm H(2)O, p < 0.02). SensAwake did not improve WASO (ON = 74 ± 54 min vs. OFF = 78 ± 51 min, p = 0.6). There were no differences in other sleep architecture measures or patient satisfaction between the 2 modalities. AutoCPAP-measured AHI closely approximated PSG-derived (ROC AUC = 0.81 [95% CI 0.71-0.92], p = 0.0001).
CONCLUSIONS: SensAwake provides similar control of the AHI to the standard AutoCPAP mode but does so at lower mean and 90% pressures. However, no measure of sleep architecture was significantly improved by the SensAwake mode during this initial acute exposure. The internal AutoCPAP AHI detection and calculation was similar to PSG-derived AHI measures. Longer term studies are needed to evaluate any long-term influence of SensAwake on WASO.

Entities:  

Keywords:  AutoCPAP; CPAP; polysomnography; wake after sleep onset

Mesh:

Year:  2011        PMID: 21677895      PMCID: PMC3113964          DOI: 10.5664/JCSM.1066

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  20 in total

1.  Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP.

Authors:  C F George
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 3.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

4.  Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea.

Authors:  N S Marshall; A M Neill; A J Campbell; D S Sheppard
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

Review 5.  Flexible pressure delivery modification of continuous positive airway pressure for obstructive sleep apnea does not improve compliance with therapy: systematic review and meta-analysis.

Authors:  Jessie P Bakker; Nathaniel S Marshall
Journal:  Chest       Date:  2010-12-30       Impact factor: 9.410

6.  Comparative study of autotitrating and fixed-pressure CPAP in the home: a randomized, single-blind crossover trial.

Authors:  Craig Hukins
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

7.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

8.  Simultaneous laboratory-based comparison of ResMed Autoset with polysomnography in the diagnosis of sleep apnoea/hypopnoea syndrome.

Authors:  P Mayer; J C Meurice; F Philip-Joet; A Cornette; D Rakotonanahary; N Meslier; J L Pepin; P Lévy; D Veale
Journal:  Eur Respir J       Date:  1998-10       Impact factor: 16.671

9.  Evaluation of autoCPAP devices in home treatment of sleep apnea/hypopnea syndrome.

Authors:  J C Meurice; A Cornette; F Philip-Joet; J L Pepin; P Escourrou; P Ingrand; D Veale
Journal:  Sleep Med       Date:  2007-07-16       Impact factor: 3.492

10.  Randomized short-term trial of two autoCPAP devices versus fixed continuous positive airway pressure for the treatment of sleep apnea.

Authors:  Oliver Senn; Thomas Brack; Felix Matthews; Erich W Russi; Konrad E Bloch
Journal:  Am J Respir Crit Care Med       Date:  2003-10-02       Impact factor: 21.405

View more
  6 in total

Review 1.  APAP, BPAP, CPAP, and New Modes of Positive Airway Pressure Therapy.

Authors:  Karin G Johnson
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Treatments for Obstructive Sleep Apnea.

Authors:  Michael W Calik
Journal:  J Clin Outcomes Manag       Date:  2016-04

3.  A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea.

Authors:  Ian M Colrain; Jed Black; Lawrence C Siegel; Richard K Bogan; Philip M Becker; Mehran Farid-Moayer; Rochelle Goldberg; D Alan Lankford; Andrew N Goldberg; Atul Malhotra
Journal:  Sleep Med       Date:  2013-07-17       Impact factor: 3.492

Review 4.  Innovative treatments for adults with obstructive sleep apnea.

Authors:  Terri E Weaver; Michael W Calik; Sarah S Farabi; Anne M Fink; Maria T Galang-Boquiren; Mary C Kapella; Bharati Prasad; David W Carley
Journal:  Nat Sci Sleep       Date:  2014-11-18

5.  Combination of obstructive sleep apnoea and insomnia treated by continuous positive airway pressure with the SensAwake pressure relief technology to assist sleep: a randomised cross-over trial protocol.

Authors:  Jean Louis Pepin; Frédéric Gagnadoux; Alison Foote; Rachel Vicars; Bhavi Ogra; Véronique Viot-Blanc; Meriem Benmerad; Marie-Pia D'Ortho; Renaud Tamisier
Journal:  BMJ Open       Date:  2017-10-27       Impact factor: 2.692

6.  A Randomized Crossover Trial of a Pressure Relief Technology (SensAwake™) in Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea.

Authors:  Richard K Bogan; Charles Wells
Journal:  Sleep Disord       Date:  2017-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.